ZA962526B - Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein - Google Patents

Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein

Info

Publication number
ZA962526B
ZA962526B ZA962526A ZA962526A ZA962526B ZA 962526 B ZA962526 B ZA 962526B ZA 962526 A ZA962526 A ZA 962526A ZA 962526 A ZA962526 A ZA 962526A ZA 962526 B ZA962526 B ZA 962526B
Authority
ZA
South Africa
Prior art keywords
protein
human papillomavirus
synthetic
hpv6
hybrid
Prior art date
Application number
ZA962526A
Other languages
English (en)
Inventor
Kathryn J Hofmann
Kathrin U Jansen
Michael P Neeper
Joseph G Joyce
Hugh A George
E Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA962526(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA962526B publication Critical patent/ZA962526B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA962526A 1995-03-30 1996-03-29 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein ZA962526B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41357295A 1995-03-30 1995-03-30
US41357195A 1995-03-30 1995-03-30

Publications (1)

Publication Number Publication Date
ZA962526B true ZA962526B (en) 1996-09-04

Family

ID=27022236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962526A ZA962526B (en) 1995-03-30 1996-03-29 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein

Country Status (21)

Country Link
US (1) US6159729A (de)
EP (1) EP0817852B1 (de)
JP (1) JP3918877B2 (de)
KR (1) KR100441477B1 (de)
CN (1) CN1154732C (de)
AT (1) ATE247712T1 (de)
AU (1) AU708111B2 (de)
CZ (1) CZ291375B6 (de)
DE (1) DE69629556T2 (de)
DK (1) DK0817852T3 (de)
EA (1) EA000969B1 (de)
ES (1) ES2203691T3 (de)
HU (1) HU228490B1 (de)
IL (1) IL117591A0 (de)
NO (1) NO320086B1 (de)
NZ (1) NZ306663A (de)
PL (1) PL183299B1 (de)
PT (1) PT817852E (de)
SK (1) SK283998B6 (de)
WO (1) WO1996030520A2 (de)
ZA (1) ZA962526B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU694269B2 (en) * 1994-09-22 1998-07-16 Merck Sharp & Dohme Corp. Dna encoding human papillomavirus type 6a
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
IL132201A0 (en) * 1997-04-08 2001-03-19 Merck & Co Inc Stabilized human papillomavirus formulations
PL347472A1 (en) * 1998-08-14 2002-04-08 Merck & Co Inc Process for purifying human papillomavirus virus-like particles
DE19840263C1 (de) * 1998-09-03 2000-05-25 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en) 1998-11-23 2002-04-30 Loyola University Of Chicago Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en) 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
KR20010093290A (ko) 1999-02-05 2001-10-27 폴락 돈나 엘. 사람 파필로마바이러스 백신 제제
US7001995B1 (en) * 1999-08-25 2006-02-21 Merck & Co., Inc. Synthetic human papillomavirus genes
SI1421200T1 (sl) * 2001-08-23 2007-04-30 Merck & Co Inc Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov
EP1302550A1 (de) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Verfahren und Detektor für die Identifizierung von HPV Viren
BRPI0407877A (pt) * 2003-03-07 2006-03-01 Merck & Co Inc conjugado de peptìdeo-proteìna, vacina para a prevenção ou melhora da infecção pelo vìrus influenza, e, método para induzir um resposta imune em um paciente
ES2381964T3 (es) * 2003-03-24 2012-06-04 Merck Sharp & Dohme Corp. Expresión optimizada de L1 de VPH 31 en levadura
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
JP4498357B2 (ja) 2003-09-25 2010-07-07 サード・ウェーブ・テクノロジーズ・インク Ｈｐｖの検出法
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
BRPI0509079B8 (pt) * 2004-03-24 2021-07-06 Merck & Co Inc molécula de ácido nucléico, vetor, célula hospedeira, partículas tipo vírus, método para produzir vlps, vacina, composições farmacêuticas, e, métodos para evitar infecção por hpv e para induzir uma resposta imune em um animal
WO2006063065A2 (en) 2004-12-08 2006-06-15 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
CN101341257B (zh) * 2004-12-10 2012-10-10 杰纳罗生物系统有限责任公司 使用核酸探针、微珠和荧光激活的细胞分选器(facs)检测人乳头状瘤病毒(hpv)
KR20080084809A (ko) * 2005-11-15 2008-09-19 게노이드 케이에프티. 병원체를 검출하는 방법
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
KR20090073987A (ko) * 2007-12-31 2009-07-03 정운원 인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
CA2799205A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
EP2638058B1 (de) 2010-11-12 2017-01-11 Merck Sharp & Dohme Corp. Enolase-peptid-konjugat-impfstoffe gegen staphylococcus aureus
CN103717741B (zh) 2011-06-15 2016-04-13 中央大学校产学协力团 用于提高人乳头瘤病毒l1蛋白产量的方法
US10513541B2 (en) 2015-12-04 2019-12-24 Xiamen University Mutant of L1 protein of human papillomavirus type 11
JP7290258B2 (ja) * 2018-09-26 2023-06-13 厦▲門▼大学 ヒトパピローマウイルス５１型のｌ１タンパク質の変異型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233639T2 (de) * 1991-07-19 2007-05-31 Csl Ltd., Parkville Polynukleotidabschnitt des HPV16-Genoms
ATE296111T1 (de) * 1993-03-09 2005-06-15 Univ Rochester Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen

Also Published As

Publication number Publication date
WO1996030520A3 (en) 1996-11-07
EA000969B1 (ru) 2000-08-28
NO974514D0 (no) 1997-09-29
PT817852E (pt) 2003-12-31
CZ291375B6 (cs) 2003-02-12
HU228490B1 (en) 2013-03-28
AU708111B2 (en) 1999-07-29
PL183299B1 (pl) 2002-06-28
PL322588A1 (en) 1998-02-02
EA199700281A1 (ru) 1998-04-30
ATE247712T1 (de) 2003-09-15
EP0817852B1 (de) 2003-08-20
WO1996030520A2 (en) 1996-10-03
HUP9801608A2 (hu) 1998-10-28
JP3918877B2 (ja) 2007-05-23
CN1154732C (zh) 2004-06-23
NO974514L (no) 1997-11-27
EP0817852A2 (de) 1998-01-14
SK129397A3 (en) 1998-05-06
HUP9801608A3 (en) 1999-04-28
ES2203691T3 (es) 2004-04-16
JPH11503313A (ja) 1999-03-26
AU5527796A (en) 1996-10-16
KR100441477B1 (ko) 2004-10-06
DK0817852T3 (da) 2003-11-24
NO320086B1 (no) 2005-10-24
SK283998B6 (sk) 2004-07-07
CN1185810A (zh) 1998-06-24
NZ306663A (en) 1999-10-28
DE69629556T2 (de) 2004-06-17
DE69629556D1 (de) 2003-09-25
CZ309197A3 (cs) 1998-02-18
KR19980703391A (ko) 1998-10-15
US6159729A (en) 2000-12-12
IL117591A0 (en) 1996-07-23

Similar Documents

Publication Publication Date Title
PL322588A1 (en) Synthetic hybrid dna l1 hpv6/11 encoding l1 protein of human pailloma virus type 11
BG100974A (en) Vaccines against papillomavirus
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
NZ306009A (en) Medical database system, unique identifier assigned to files, machine readable version of identifier included in hard copies
HUP9802556A1 (hu) Eljárás és készítmény kötőszöveti kapcsolódások gyógyítására és helyreállítására
NL300272I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
GB2302329B (en) Yeast strains
BG102616A (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
EP0982988A4 (de) Im wesentlichen reines zonulin als physiologischer modulator von "tight junctions" bei säugern
IL122606A (en) (S)-hydroxa-nitrile-lyase
CA2200582A1 (en) Dna encoding human papillomavirus type 6a
TW261532B (de)
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
CA2216827A1 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
DE59702821D1 (en) Dimethyl-substituierte cyclohexandienderivate
DE59611353D1 (de) Transketolase-verwandtes protein